Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Apple Hospitality REIT | APLE | Nov 18, 2024 | 15.52 | +0.13 |
Applied Digital | APLD | Nov 18, 2024 | 7.75 | +7.19 |
Applied DNA Sciences | APDN | Nov 18, 2024 | 0.17 | +4.63 |
Applied Industrial Technologies | AIT | Nov 18, 2024 | 267.26 | +0.20 |
Applied Materials | AMAT | Nov 18, 2024 | 170.73 | +1.10 |
Applied Optoelectronics | AAOI | Nov 18, 2024 | 27.32 | +1.94 |
Applied Therapeutics | APLT | Nov 18, 2024 | 8.65 | -0.46 |
Applovin A | APP | Nov 18, 2024 | 298.00 | +2.37 |
AppTech Payments | APCX | Nov 18, 2024 | 0.50 | +5.96 |
Aprea Therapeutics | APRE | Nov 18, 2024 | 2.98 | -8.31 |
AptarGroup | ATR | Nov 18, 2024 | 166.69 | +0.12 |
Aptevo Therapeutics | APVO | Nov 18, 2024 | 0.22 | +2.23 |
Aptiv | APTV | Nov 18, 2024 | 52.71 | -0.42 |
Aptorum Group A | APM | Nov 18, 2024 | 0.55 | -19.94 |
Aptose Biosciences | APTO | Nov 18, 2024 | 0.34 | -5.74 |
APx Acquisition I A | APXI | Nov 18, 2024 | 11.87 | 0.00 |
APx Acquisition I Unit | APXIU | Nov 18, 2024 | 11.55 | 0.00 |
Apyx Medical | APYX | Nov 18, 2024 | 1.23 | -2.38 |
Aqua Metals | AQMS | Nov 18, 2024 | 1.58 | -5.39 |
AquaBounty Technologies | AQB | Nov 18, 2024 | 1.00 | +0.50 |
Aquaron Acquisition | AQU | Nov 18, 2024 | 11.05 | +0.45 |
Aquaron Acquisition Units | AQUNU | Nov 18, 2024 | 11.15 | 0.00 |
Aquestive Therapeutics | AQST | Nov 18, 2024 | 4.64 | +4.50 |
Aramark | ARMK | Nov 18, 2024 | 37.25 | -0.29 |
ARB IOT Group | ARBB | Nov 18, 2024 | 0.52 | +8.13 |
Arbe Robotics | ARBE | Nov 18, 2024 | 1.69 | +4.66 |
Arbor Realty Trust | ABR | Nov 18, 2024 | 14.78 | +1.51 |
Arbor Realty Trust D Pref | ABR-D | Nov 18, 2024 | 18.58 | -1.17 |
Arbor Realty Trust E Pref | ABR-E | Nov 18, 2024 | 19.05 | -0.52 |
Arbor Realty Trust F Pref | ABR-F | Nov 18, 2024 | 20.31 | +0.51 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.